• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在用低剂量利什曼原虫主要亚种进行皮内攻击后,C57BL/6小鼠的初次免疫需要CD8 + T细胞。

CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.

作者信息

Belkaid Yasmine, Von Stebut Esther, Mendez Susana, Lira Rosalia, Caler Elisabet, Bertholet Sylvie, Udey Mark C, Sacks David

机构信息

Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, and Dermatology Branch, Division of Clinical Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

J Immunol. 2002 Apr 15;168(8):3992-4000. doi: 10.4049/jimmunol.168.8.3992.

DOI:10.4049/jimmunol.168.8.3992
PMID:11937556
Abstract

Standard murine models of cutaneous leishmaniasis, involving s.c. inoculation of large numbers of Leishmania major promastigotes, have not supported an essential role for CD8(+) T cells in the control of primary infection. Recently, a L. major model combining two main features of natural transmission, low parasite dose and inoculation into a dermal site, has been established in resistant C57BL/6 mice. In the present studies, C57BL/6 mice with CD8(+) T cell deficiencies, including CD8(-/-) and CD8-depleted mice, failed to control the growth of L. major following inoculation of 100 metacyclic promastigotes into the ear dermis. The resulting dermal pathology was minor and delayed. Lesion formation in wild-type mice was coincident with the killing of parasites in the inoculation site. Both events were associated with the accumulation of CD8(+) T lymphocytes in the skin and with the capacity of CD8(+) T cells recovered from draining lymph nodes or infected dermis to release IFN-gamma following coculture with infected dendritic cells. Reconstitution of resistance to L. major in RAG(-/-) mice using T cells from naive donors was optimal when both CD4(+) and CD8(+) T cells were transferred. Primed CD8(+) T lymphocytes obtained from C57BL/6 mice during the acute stage of infection were able to mediate both pathology and immunity when transferred alone. The low dose, intradermal challenge model reveals that CD8(+) T cells play an essential role in both pathogenesis of and immunity to primary infection with L. major in the skin.

摘要

皮肤利什曼病的标准小鼠模型,涉及皮下接种大量硕大利什曼原虫前鞭毛体,并未支持CD8(+) T细胞在原发性感染控制中起关键作用。最近,在具有抗性的C57BL/6小鼠中建立了一种结合自然传播两个主要特征的硕大利什曼原虫模型,即低寄生虫剂量和接种到真皮部位。在本研究中,具有CD8(+) T细胞缺陷的C57BL/6小鼠,包括CD8(-/-)小鼠和CD8耗尽的小鼠,在将100个循环前鞭毛体接种到耳部真皮后,无法控制硕大利什曼原虫的生长。由此产生的皮肤病理学变化轻微且延迟。野生型小鼠的病变形成与接种部位寄生虫的杀伤同时发生。这两个事件都与皮肤中CD8(+) T淋巴细胞的积累以及从引流淋巴结或感染真皮中回收的CD8(+) T细胞在与感染的树突状细胞共培养后释放IFN-γ的能力有关。当同时转移CD4(+)和CD8(+) T细胞时,使用来自未免疫供体的T细胞重建RAG(-/-)小鼠对硕大利什曼原虫的抗性最为理想。在感染急性期从C57BL/6小鼠获得的致敏CD8(+) T淋巴细胞单独转移时能够介导病理学变化和免疫反应。低剂量皮内攻击模型表明,CD8(+) T细胞在皮肤中硕大利什曼原虫原发性感染的发病机制和免疫中均起关键作用。

相似文献

1
CD8+ T cells are required for primary immunity in C57BL/6 mice following low-dose, intradermal challenge with Leishmania major.在用低剂量利什曼原虫主要亚种进行皮内攻击后,C57BL/6小鼠的初次免疫需要CD8 + T细胞。
J Immunol. 2002 Apr 15;168(8):3992-4000. doi: 10.4049/jimmunol.168.8.3992.
2
The potency and durability of DNA- and protein-based vaccines against Leishmania major evaluated using low-dose, intradermal challenge.使用低剂量皮内攻击法评估基于DNA和蛋白质的针对硕大利什曼原虫疫苗的效力和持久性。
J Immunol. 2001 Apr 15;166(8):5122-8. doi: 10.4049/jimmunol.166.8.5122.
3
A natural model of Leishmania major infection reveals a prolonged "silent" phase of parasite amplification in the skin before the onset of lesion formation and immunity.硕大利什曼原虫感染的自然模型显示,在病变形成和免疫反应开始之前,寄生虫在皮肤中存在一个延长的“沉默”扩增阶段。
J Immunol. 2000 Jul 15;165(2):969-77. doi: 10.4049/jimmunol.165.2.969.
4
Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.对BALB/c小鼠进行低剂量硕大利什曼原虫和亚马逊利什曼原虫循环前鞭毛体的皮内接种,会诱导不同的免疫寄生虫过程和保护状态。
Int J Parasitol. 2003 Oct;33(12):1373-83. doi: 10.1016/s0020-7519(03)00179-6.
5
The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum.通过耳部真皮接种感染硕大利什曼原虫的BALB/c小鼠的CD4 T淋巴细胞产生的细胞因子水平和模式取决于接种物的感染性和大小。
Infect Immun. 2003 May;71(5):2674-83. doi: 10.1128/IAI.71.5.2674-2683.2003.
6
Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.尽管在C57BL/6小鼠中由一株硕大利什曼原虫产生了Th1极化,但感染仍未愈合。
J Immunol. 2005 Mar 1;174(5):2934-41. doi: 10.4049/jimmunol.174.5.2934.
7
Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells.DNA疫苗接种后体内维持Th1免疫的要求:CD8 + T细胞的潜在免疫调节作用。
J Immunol. 2000 Jul 15;165(2):915-24. doi: 10.4049/jimmunol.165.2.915.
8
Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection.在硕大利什曼原虫感染后,是淋巴结驻留树突状细胞而非皮肤来源的树突状细胞启动特异性T细胞反应。
J Immunol. 2006 Jul 15;177(2):1250-6. doi: 10.4049/jimmunol.177.2.1250.
9
Priming of CD8+ and CD4+ T cells in experimental leishmaniasis is initiated by different dendritic cell subtypes.在实验性利什曼病中,CD8 +和CD4 + T细胞的致敏由不同的树突状细胞亚型启动。
J Immunol. 2009 Jan 15;182(2):774-83. doi: 10.4049/jimmunol.182.2.774.
10
Cross-talk between CD8(+) and CD4(+) T cells in experimental cutaneous leishmaniasis: CD8(+) T cells are required for optimal IFN-gamma production by CD4(+) T cells.实验性皮肤利什曼病中CD8(+)和CD4(+) T细胞之间的相互作用:CD4(+) T细胞产生最佳干扰素-γ需要CD8(+) T细胞。
Parasite Immunol. 2003 Nov-Dec;25(11-12):559-67. doi: 10.1111/j.0141-9838.2004.00668.x.

引用本文的文献

1
Lack of Hypoxia Inducible Factor-1α Influences on Macrophages Ability to Deal with In Vitro and Affects Pathology In Vivo.缺氧诱导因子-1α的缺失对巨噬细胞体外处理能力的影响及对体内病理学的影响。
JID Innov. 2025 Jan 8;5(3):100347. doi: 10.1016/j.xjidi.2025.100347. eCollection 2025 May.
2
Advances in Vaccines: Current Development and Future Prospects.疫苗进展:当前发展与未来前景
Pathogens. 2024 Sep 20;13(9):812. doi: 10.3390/pathogens13090812.
3
Autophagy induced macrophages by α-alumina(α-AL2O3) conjugated cysteine peptidase, enhances the cytotoxic activity of CD8 T lymphocytes against .
由α-氧化铝(α-AL2O3)偶联半胱氨酸肽酶诱导的自噬增强了CD8 T淋巴细胞对……的细胞毒性活性。 (原文句末“against”后缺少内容)
Bioimpacts. 2023;13(5):393-403. doi: 10.34172/bi.2023.25282. Epub 2023 Jan 7.
4
Deletion of MIF gene from live attenuated LdCen parasites enhances protective CD4 T cell immunity.从减毒的 LdCen 寄生虫中删除 MIF 基因可增强保护性 CD4 T 细胞免疫。
Sci Rep. 2023 May 5;13(1):7362. doi: 10.1038/s41598-023-34333-2.
5
Pathogenic role of the staphylococcal accessory gene regulator quorum sensing system in atopic dermatitis.金黄色葡萄球菌附属基因调控器群体感应系统在特应性皮炎中的致病作用。
Front Cell Infect Microbiol. 2023 Apr 14;13:1178650. doi: 10.3389/fcimb.2023.1178650. eCollection 2023.
6
Evaluation of calpain T-cell epitopes as vaccine candidates against experimental Leishmania major infection: a pilot study.评估钙蛋白酶T细胞表位作为抗实验性硕大利什曼原虫感染疫苗候选物:一项初步研究。
Parasitol Res. 2022 Nov;121(11):3275-3285. doi: 10.1007/s00436-022-07657-7. Epub 2022 Sep 14.
7
Healed Lesions of Human Cutaneous Leishmaniasis Caused By Do Not Shelter Persistent Residual Parasites.人类皮肤利什曼病的愈合病变不会庇护持续残留的寄生虫。
Front Cell Infect Microbiol. 2022 Jul 27;12:839216. doi: 10.3389/fcimb.2022.839216. eCollection 2022.
8
In-silico design of an immunoinformatics based multi-epitope vaccine against Leishmania donovani.基于免疫信息学的利什曼原虫多表位疫苗的计算机设计。
BMC Bioinformatics. 2022 Aug 5;23(1):319. doi: 10.1186/s12859-022-04816-6.
9
VAMP3 and VAMP8 Regulate the Development and Functionality of Parasitophorous Vacuoles Housing Leishmania amazonensis.VAMP3 和 VAMP8 调节寄生空泡的发育和功能,这些空泡容纳 Leishmania amazonensis。
Infect Immun. 2022 Mar 17;90(3):e0018321. doi: 10.1128/IAI.00183-21. Epub 2022 Feb 7.
10
-Sialidase as a Potential Vaccine Target Against Chagas Disease.唾液酸酶作为恰加斯病潜在疫苗靶点
Front Cell Infect Microbiol. 2021 Oct 26;11:768450. doi: 10.3389/fcimb.2021.768450. eCollection 2021.